This application is a filing under 35 U.S.C. 371 of international application number PCT/SE2015/050192, filed Feb. 19, 2015, which claims priority to SE application number 1450373-4, filed Mar. 31, 2014, the entire disclosures of each of which are hereby incorporated by reference.
The present invention relates to a product and method for cell preservation, such as cell banking of any type of cells for subsequent scientific or medical use. More closely, the invention relates to a product and a method for cryopreservation of cells using vacuum tubes provided with freeze media/cryopreservation liquid.
Today several cell banks exist which store cells, for example human placental or umbilical cord stem cells, for future medical use. There are also cell banks which store cells, cultivated in for example bioreactors, for scientific purposes. Common for all cell banks is that the cells are stored by cryopreservation usually in liquid nitrogen at −196° C.
Cryopreservation is a very manual and time consuming task usually performed under laminar air flow (LAF). Furthermore, it includes several steps with open handling which increases the risk of contamination. Due to the number of steps during traditional cell banking, batch to batch variations might also occur. During cryopreservation of cells, time and temperature are critical factors to eliminate stress such as asphyxiation.
Containers under vacuum, such as the Vacutainer™, are well-established products used at hospitals and care centers for rapid blood sampling. The containers comprise a vacuum tube that aseptically draws blood through a sleeved covered needle. The vacuum tube is available in various volumes and often pre-coated with various compounds to prevent for example blood clotting. The vacuum tube is inserted into the access device and when the sleeve protected needle penetrates the silicon cap on the vacuum tube the blood automatically will be withdrawn from the patient.
It would be desirable to have a product with which cell banking could be performed without bringing the cells out of the bioreactor and which significantly would shorten the time from bioreactor to the fridge. This would provide a powerful tool to establish large cell banks with very little effort.
The present invention provides a product and a method for rapid cell banking which reduces possible contamination and handling times and efforts compared to prior art.
Thus in a first aspect the invention relates to a product for cryopreservation of cells, comprising a vacuum tube provided with freeze media, and a penetratable and preferably removable cap on said tube.
Preferably the freeze media is DMSO, glycerol or methyl cellulose and the vacuum tube is filled with 5-20% v/v, preferably 10% v/v freeze media.
In one embodiment an access device is provided for receiving said vacuum tube. The access device is provided with a hollow needle to be inserted into the vacuum tube and also provided with a connector for connection to a cell source, such as a cell culture in a bioreactor.
In a second aspect, the invention relates to a method for cryopreservation of cells, comprising sampling or harvesting cells into a vacuum tube provided with freeze media; closing said tube with a penetratable cap; and freezing said tube.
In a preferred method for cryopreservation of cells, the method comprises cultivating cells in a bioreactor; harvesting or sampling cells from said bioreactor into a vacuum tube provided with freeze media, wherein the cells are instantly mixed with the freeze media; removing said tube from said bioreactor; and freezing said tube and its content.
Preferably the freeze media is DMSO, glycerol or methyl cellulose and the vacuum tube is filled with 5-20% v/v, preferably 10% v/v freeze media.
In a preferred embodiment, the cells are cultivated as a perfusion culture. Preferably the cells are cultivated to 10-200 MVC/mL.
If desired the cells are incubated before freezing.
One or more steps of the method may be automated.
The method of the invention would nearly eliminate the time from cell harvesting to cryopreservation, since it will be done in one step. Preferably, the cryopreservation tubes are stored cold before the procedure starts.
The present invention will now be described in relation to a non-limiting example and the accompanying figure.
Conventional 5 ml vacuum tubes are filled with 0.5 ml concentrated DMSO (freeze media) using a syringe. A CHO (Chinese Hamster Ovary) culture is brought to up to 10-100 MVC/mL, preferably using perfusion culture. The access device with sleeve protected needle (6) is attached to the bioreactor via the connector (8). Cryo-liquid prepared vacuum tubes according to the invention are used to draw cell samples from the bioreactor. The vacuum tubes are inserted in the access device and the vacuum draws the cells broth into the tube through the needle of the access device. The cell broth and the freeze media are instantly mixed.
Thereafter the filled cryo prepared vacuum tubes are directly transferred to a cell banking fridge. If necessary, the cells in the tubes are shortly incubated before freezing.
The procedure to draw cell samples from bioreactors does not damage the cells and is very fast which enables production of large cell banks with minimum of open handling. If desired, the process may be automated.
Number | Date | Country | Kind |
---|---|---|---|
1450373-4 | Mar 2014 | SE | national |
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/SE2015/050192 | 2/19/2015 | WO | 00 |
Publishing Document | Publishing Date | Country | Kind |
---|---|---|---|
WO2015/152788 | 10/8/2015 | WO | A |
Number | Name | Date | Kind |
---|---|---|---|
5296197 | Newberg | Mar 1994 | A |
5752936 | Chen | May 1998 | A |
8240717 | Freter | Aug 2012 | B2 |
9375168 | Shacham | Jun 2016 | B2 |
9381134 | Rettinghaus et al. | Jul 2016 | B2 |
20020055166 | Cannon | May 2002 | A1 |
20050245899 | Swisher | Nov 2005 | A1 |
Number | Date | Country |
---|---|---|
102742568 | Oct 2012 | CN |
202723863 | Feb 2013 | CN |
10243129 | Apr 2004 | DE |
1413874 | Apr 2004 | EP |
2111795 | Oct 2009 | EP |
3125687 | Feb 2017 | EP |
9009431 | Aug 1990 | WO |
2010108091 | Sep 2010 | WO |
2015152788 | Oct 2015 | WO |
Entry |
---|
Zuckerman “Propagation of Parasitic Protozoa in Tissue Culture and Avian Embryos” (1966), Annals of NY Academy of Sciences, vol. 139: 24-38. (Year: 1966). |
Hubalek “Protectants used in the cryopreservation of microorganisms” (2003) Cryobiology, vol. 46: 205-229. (Year: 2003). |
Fan et al. “Transgenic rabbits as therapeutic protien bioreactors and human disease models”, 2003, Pharmacology & Therapeutics, vol. 99: 261-282 (Year: 2003). |
Ochieng A. and Gray M.A., “Establishment of Cultures of Trypanosome Congolense from Infected Cattle”, Recent Advances in Medical Research with a Symposium on Environmental and Occupational Health, Proceedings of the 10th Annual Medical Scientific Conference, KEMRI/KETRI, Nairobi, Kenya, 1989, pp. 73-76; the abstract; sections “Ampoules for collection of infected blood”, “Collection of blood from infected cattle in the field” and “Cryopreservation”. |
Gray M. A. et al., “Drug sensitivity screening in vitro of populations of trypanosoma congolense originating from cattle and tsetse flies at Nguruman, Kenya”, Acta Tropica, 1993, vol. 55, pp. 1-9; section “Collection of trypanosomes from infected cattle”. |
Clincke M-F. et al, “Very High Density of Chinese Hamster Ovary Cells in Perfusion by Alternating Tangential Flow or Tangential Flow Filtration in WAVE Bioreactors(TM)—Part II: Applications for Antibody Production and Cryopreservation”, Biotechnol. Prog., 2013, vol. 29, pp. 768-777. |
Buravkova L. et al., “Cell-to-cell interactions in changed gravity: Ground-based and flight experiments”, Acta Astronautica, 2005, vol. 2005, vol. 57, pp. 67-74. |
International Search Report and Written Opinion regarding International Application No. PCT/SE2015/050192, dated Jun. 9, 2015, 15 pages. |
International Preliminary Report on Patentability received for PCT Patent Application No. PCT/SE2015/050192, dated Oct. 4, 2016, 8 pages. |
Extended European Search Report received for European Patent Application No. 15773020.1, dated Jan. 3, 2017, 10 pages. |
Origen: “CrypPur(TM) Cryopreservation Solutions”, available online at <http://www.questbiomedical.com/Content/PDF/Leaflet22.pdf>, Oct. 27, 2010, pp. 1-2. |
bd.com, “Needleless Blood Collection from BD Q-Syte (TM) Luer Access Split Septum”, available online at <http://www.bd.com/resource.aspx?IDX=14302>, Dec. 2009, pp. 1-2. |
ATCC; Animal Cell Culture Basics:“Animal Cell Culture Guide Tips and Techniques for Continuous Cell lines”, available online at <https://www.atcc.org/˜/media/AnimCellCulture_Guide.ashx>, Jan. 2012, 40 pages. |
TPP:, “Home of Tissue Culture TubeSpin Bioreactor 50 with Septum”, available online at <http://www.tpp/ch/page/downloads/data_sheets/80708-TubeSpin50-with-septum-D_E-09-13.pdf> ,Sep. 1, 2013. |
Office Action for EP Patent Appl. No. 15 773 020.1, dated May 22, 2018, 5 pages. |
Paulo S. Monzani et al., “Transgenic Bovine as Bioreactors: Challenges and Perspectives,” Bioengineered, vol. 7, No. 3, Apr. 8, 2016, pp. 123-131. |
Office Action for EP Patent Appl. No. 15 773 020.1, dated May 15, 2019, 12 pages. |
Chinese Office Action for CN Application 201580017762.5 dated Aug. 17, 2020 (14 pages with English translation). |
Number | Date | Country | |
---|---|---|---|
20170013825 A1 | Jan 2017 | US |